Employer purchasers have largely been on the sidelines when it comes to policy proposals that target high healthcare prices.

A prediction for 2025 by Marci Chodroff, M.D., vice president of Medical Affairs at Prime Therapeutics and Managed Healthcare ...

Centene Corporation’s Ambetter Health Solutions names Alan Silver as the first president of Individual Coverage Health ...

The move means the pulmonary arterial hypertension drug is now available in the United States, Europe, and the United Kingdom ...

Kimberly Westrich, M.A., chief strategy officer of National Pharmaceutical Council, shares her prediction for 2025.

In a review of previous studies, researchers found that the images seen on social media contribute to taking actions that are both beneficial with patients seeking dermatological care and unfavorable ...

The target action date for Rexulti in combination with sertraline to treat patients with post-traumatic stress disorder, ...

Out of 6,540 patients involved in a study, 7.1% of those with AD had mobility impairment compared to 3.9% of those without AD ...

The target action date for Rexulti in combination with sertraline to treat patients with post-traumatic stress disorder, ...

Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.

Health plans will need to navigate a difficult financial environment caused by increased healthcare costs and potential ...

Fianlimab plus Libtayo demonstrated persistent and significant clinical activity in patients with advanced melanoma.